文献速递创伤与烧伤重症综合管理与镇静镇痛

创伤患者中并非所有游离线粒体DNA都相同

NOT ALL CELL-FREE MITOCHONDRIAL DNA IS EQUAL IN TRAUMA PATIENTS.
PubMed 文献 · Shock · 2022-07-30
一句话结论创伤患者血浆中>95%的游离线粒体DNA为离心可去除的大分子形式,其与预后无关;低分子量游离线粒体DNA才与损伤严重度、休克、多器官衰竭和炎症指标强相关。

本文指出游离线粒体DNA作为损伤相关分子模式通过Toll样受体9激活固有免疫,但既往创伤研究中其升高幅度、绝对浓度与不良结局的关联差异很大。健康人群中>95%的游离线粒体DNA可经0.45至5微米范围离心或过滤去除,提示血浆中存在较大形式的含线粒体DNA复合物,且各研究离心速度不一致可能导致混杂。本研究对25例严重创伤患者显示,血浆中>95%的游离线粒体DNA在16,000g离心后去除,但大分子形式与结局、损伤/休克严重度、多器官衰竭及炎症标志物均不相关,而低分子量游离线粒体DNA与这些变量强相关。

要点

  • 25例严重创伤患者血浆中>95%的游离线粒体DNA在16,000g离心后去除,提示以较大形式为主。
  • 大分子形式游离线粒体DNA与损伤/休克严重度、多器官衰竭及炎症标志物均无相关。
  • 低分子量游离线粒体DNA与损伤/休克严重度、多器官衰竭及炎症标志物强相关。
  • 健康人群>95%的游离线粒体DNA可经0.45至5微米范围离心或过滤去除,各研究离心速度不一致可造成混杂。
  • 创伤患者中较大形式线粒体DNA的临床相关性此前未知,本研究显示其与结局无关。

适用人群与场景

  • 25例严重创伤患者。

研究设计与关键结果

  • 研究类型为对25例严重创伤患者的观察分析,检测血浆游离线粒体DNA。
  • 创伤患者血浆中>95%的游离线粒体DNA在16,000g离心后去除。
  • 较大形式游离线粒体DNA与结局、损伤/休克严重度、多器官衰竭及炎症标志物均不相关。
  • 低分子量游离线粒体DNA与损伤/休克严重度、多器官衰竭及炎症标志物强相关。
  • 健康个体中>95%的游离线粒体DNA可经0.45至5微米范围离心或过滤从血浆去除。
  • 各研究用于制备无细胞血浆的离心速度很少一致,可能导致游离线粒体DNA混合群体并混杂结局关联。

证据类型、等级与局限

  • 证据类型:对25例严重创伤患者的观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Mitochondrial DNA (mtDNA) acts as a proinflammatory damage-associated molecular pattern that stimulates innate immune activation via Toll-like receptor 9, similarly to bacterial DNA. A number of clinical studies have measured elevated cell-free mtDNA in the plasma of trauma patients, thought to originate from tissue injury and inflammatory processes; however, the magnitude of this increase, the absolute concentration, and the association with poor outcomes varies considerably across studies. Measurements of cell-free mtDNA in healthy individuals have shown that the majority of "cell-free" mtDNA (>95%) can be centrifuged/filtered from plasma in the size range of 0.45 to 5 μm, suggesting that there are larger forms of mtDNA-containing complexes in the plasma that could be considered cell-free. Whether this is true for trauma patients (and other relevant disease states) and the clinical relevance of the larger forms of mtDNA is unknown. These findings from healthy individuals also suggest that the centrifugation speeds used to generate cell-free plasma (which are rarely consistent among studies) could result in mixed populations of cell-free mtDNA that could confound associations with outcomes. We demonstrate in this study of 25 major trauma patients that the majority of the cell-free mtDNA in trauma patient plasma (>95%) is removed after centrifugation at 16,000g. Despite the larger forms of mtDNA being predominant, they do not correlate with outcomes or expected parameters such as injury/shock severity, multiple organ failure, and markers of inflammation, whereas low-molecular-weight cell-free mtDNA correlates strongly with these variables.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Briggs GD, Gelzinnis S, Meakes S, et al. NOT ALL CELL-FREE MITOCHONDRIAL DNA IS EQUAL IN TRAUMA PATIENTS. Shock. 2022. PMID: 36125357. doi:10.1097/SHK.0000000000001969

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。